Essential Partners’s Immuneering IMRX Stock Holding History

Essential Partners’s Portfolio IMRX Stock Details IMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12	Buy	+3	New	+$14	﹤0.01%	2832

Other funds holding IMRX

PAM

PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return

FCC

Flower City Capital Pittsford, New York $234M AUM 15.69% 1-Year Est. Return

Berman McAleer Timonium, Maryland $862M AUM 13.92% 1-Year Est. Return

FIA

FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $163M AUM 15.03% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Focus Financial Network Minneapolis, Minnesota $3.3B AUM 21.52% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Essential Partners's IMRX Position: Q3 2026 in Review

Essential Partners opened a new position in Immuneering (IMRX) in Q3 2026: 3 shares worth $12. The stake represents ﹤0.01% of the portfolio and ranks #2832 among its holdings.

10 funds tracked by Wall St. Rank hold IMRX as of Q3 2026.

Essential Partners held 3 shares of Immuneering worth $12 as of Q3 2026.
Immuneering was a new Essential Partners position in Q3 2026.
Immuneering made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2832 holding.
10 funds tracked by Wall St. Rank held Immuneering as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.